Article
Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers.
Clinical lung cancer - 1 Jan 2013
Zhang Yongjun, Hua Shi, Zhang Aiqin, Kong Xiangming, Jiang Chuming, Deng Dehou, Wenlong Bao
Abstract excerpt
BACKGROUND: Recently, polymorphisms in COMT (catechol-O-methyltransferase), PLCH1 (phosphoinositide-specific phospholipase C eta 1), and CYP17A1 (cytochrome P450 17A1) were found to be associated with the development of lung cancer in a non-Chinese population. AIMS: To explore the potential association between single-nucleotide polymorphism (SNP) in COMT, PLCH1, CYP17A1, and non-small-cell lung cancer (NSCLC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
